274 related articles for article (PubMed ID: 33789469)
1. Management of tenosynovial giant cell tumour of the foot and ankle.
Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
[TBL] [Abstract][Full Text] [Related]
2. Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.
Ikuta Y; Nakasa T; Sumii J; Nekomoto A; Kawabata S; Adachi N
Mod Rheumatol Case Rep; 2023 Jun; 7(2):483-487. PubMed ID: 36484489
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
[TBL] [Abstract][Full Text] [Related]
4. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
6. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
[TBL] [Abstract][Full Text] [Related]
7. The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
Bernthal NM; Spierenburg G; Healey JH; Palmerini E; Bauer S; ; Gelderblom H; Staals EL; Lopez-Bastida J; Fronk EM; Ye X; Laeis P; van de Sande MAJ
Orphanet J Rare Dis; 2021 Apr; 16(1):191. PubMed ID: 33926503
[TBL] [Abstract][Full Text] [Related]
8. Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).
Lingamfelter M; Novaczyk ZB; Cheng EY
JBJS Essent Surg Tech; 2022; 12(2):. PubMed ID: 36741035
[TBL] [Abstract][Full Text] [Related]
9. Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study.
Spierenburg G; Staals EL; Palmerini E; Randall RL; Thorpe SW; Wunder JS; Ferguson PC; Verspoor FGM; Houdek MT; Bernthal NM; Schreuder BHWB; Gelderblom H; van de Sande MAJ; van der Heijden L
Eur J Surg Oncol; 2024 Feb; 50(2):107953. PubMed ID: 38215550
[TBL] [Abstract][Full Text] [Related]
10. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
[TBL] [Abstract][Full Text] [Related]
11. Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease.
Healey JH; Bernthal NM; van de Sande M
J Am Acad Orthop Surg Glob Res Rev; 2020 Nov; 4(11):e20.00028. PubMed ID: 33156160
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
[TBL] [Abstract][Full Text] [Related]
13. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
[TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.
Takeuchi A; Nomura A; Yamamoto N; Hayashi K; Igarashi K; Tandai S; Kawai A; Matsumine A; Miwa S; Nishida Y; Nakamura T; Terauchi R; Hoshi M; Kunisada T; Endo M; Yoshimura K; Murayama T; Tsuchiya H
BMC Musculoskelet Disord; 2019 Feb; 20(1):68. PubMed ID: 30738433
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of arthroscopic excision based on the distribution of the tenosynovial giant cell tumor around knee joint.
Yoo HJ; Nam HS; Park SB; Lee YS
Knee; 2023 Mar; 41():360-372. PubMed ID: 36848705
[TBL] [Abstract][Full Text] [Related]
16. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
[TBL] [Abstract][Full Text] [Related]
17. Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA.
Dharmani C; Fofah O; Wang E; Salas M; Wooddell M; Tu N; Tse J; Near A; Tinoco G
Future Oncol; 2024; 20(16):1079-1097. PubMed ID: 38380590
[No Abstract] [Full Text] [Related]
18. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
[TBL] [Abstract][Full Text] [Related]
19. Tenosynovial giant cell tumors of the temporomandibular joint and lateral skull base: Review of 11 cases.
Carlson ML; Osetinsky LM; Alon EE; Inwards CY; Lane JI; Moore EJ
Laryngoscope; 2017 Oct; 127(10):2340-2346. PubMed ID: 27888510
[TBL] [Abstract][Full Text] [Related]
20. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
Burton TM; Ye X; Parker ED; Bancroft T; Healey J
Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
